Clinical evaluation shows chemical peels improve skin condition in patients with xeroderma pigmentosum, suggesting efficacy in lesion prevention.
Background: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by heightened sensitivity to ultraviolet radiation due to a deficiency in the endonuclease enzyme responsible for DNA repair. Aim: The study aimed to evaluate the role of chemical peels in clearing the skin background in patients with XP and reducing the rate of new lesion development. Patients and Methods: This study included 14 patients with XP, consisting of 9 males and 5 females, who underwent facial chemical peels using 30% trichloroacetic acid. The study was conducted between March 2011 and May 2012 at Al-Jamhouri Teaching Hospital in Mosul. Evaluation of results was performed by two plastic surgeons and patient satisfaction. Results: All patients underwent trichloroacetic acid peeling of the entire face, with the number of sessions varying. Specifically, one patient received 3 sessions, another patient received 4 sessions, and one patient received 6 sessions. Eight patients underwent 5 sessions, and three patients received 7 sessions of chemical peels. Patient and parent satisfaction was assessed, with 7 patients reporting high satisfaction and 7 patients indicating moderate satisfaction. Evaluation by two plastic surgeons revealed good results in 5 patients, moderate results in 7 patients, and poor results in 2 patients. Conclusion: Chemical peels offer a simple, well-tolerated procedure that effectively clears skin background changes and eliminates subclinical premalignant lesions, as diagnosed by fine needle aspiration cytology (FNAC). This procedure exhibits a prophylactic effect in XP patients and yields positive outcomes with minimal complications.
No takes yet. Share an insight, caveat, or question.
Abdulrazaq et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: